A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials

Multiple components factor into the assessment of combination safety risks when two or more novel individual products are used in combination in clinical trials. These include, but are not limited to, biology, biochemistry, pharmacology, class effects, and preclinical and clinical findings (such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Patera, Andriani C., Maidment, Julie, Maroj, Brijesh, Mohamed, Ahmed, Twomey, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205853/
https://www.ncbi.nlm.nih.gov/pubmed/37099245
http://dx.doi.org/10.1007/s40290-023-00465-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205853/
https://www.ncbi.nlm.nih.gov/pubmed/37099245
http://dx.doi.org/10.1007/s40290-023-00465-z

Ejemplares similares